bay h 4502 has been researched along with itraconazole in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 8 (38.10) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Angiolella, L; Artico, M; Botta, M; Caporuscio, F; Corelli, F; Costi, R; Di Santo, R; Forte, M; Palamara, AT; Tafi, A | 1 |
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Deising, HB; Serfling, A; Wohlrab, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Emami, S; Keighobadi, M; Tavangar, P | 1 |
| Aoki, K; Hosaka, J; Uchida, K; Yamaguchi, H | 1 |
| Cauwenbergh, G | 1 |
| Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
| Abbott, AB; Odds, FC; Webster, CE | 1 |
| Inoue, I; Kitajima, Y; Osada, K; Seishima, M | 1 |
| Hasegawa, A; Kano, R; Murai, T; Nakamura, Y; Watanabe, S | 1 |
| Reinel, D | 1 |
| Sellart-Altisent, M; Torres-Rodríguez, JM | 1 |
| Gürcan, S; Kiliç, H; Pişkin, S; Temelli, BA; Yalçin, O | 1 |
| Chen, WN; Liu, JH; Luo, DQ; Wu, LC; Yang, W | 1 |
| Arabatzis, M | 1 |
| Hu, Y; Tang, H; Wang, R; Zhang, T | 1 |
| He, Y; Tan, J; Yang, L; Zhang, J | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
1 review(s) available for bay h 4502 and itraconazole
| Article | Year |
|---|---|
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy.
Topics: 14-alpha Demethylase Inhibitors; Antiprotozoal Agents; Azoles; Humans; Leishmania; Molecular Structure; Sterol 14-Demethylase | 2017 |
20 other study(ies) available for bay h 4502 and itraconazole
| Article | Year |
|---|---|
Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
Topics: Antifungal Agents; Candida albicans; Imidazoles; Microbial Sensitivity Tests; Models, Molecular; Pyrroles; Quantitative Structure-Activity Relationship | 2005 |
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Dermatomycoses; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1991 |
New and prospective developments in antifungal drugs.
Topics: Administration, Oral; Administration, Topical; Allylamine; Antifungal Agents; Clotrimazole; Dermatomycoses; Drug Compounding; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Terbinafine; Triazoles | 1986 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
Topics: Antifungal Agents; Aspergillus; Candida; Clotrimazole; Econazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Morpholines; Triazoles | 1984 |
Different effects of azole-antifungal agents on the regulation of intracellular calcium concentration of Trichophyton rubrum.
Topics: Antifungal Agents; Azoles; Calcium; Chelating Agents; Edetic Acid; Humans; Imidazoles; Intracellular Membranes; Itraconazole; Ketoconazole; Osmolar Concentration; Trichophyton | 1996 |
Susceptibility testing of Malassezia species using the urea broth microdilution method.
Topics: Animals; Antifungal Agents; Culture Media; Humans; Imidazoles; Itraconazole; Malassezia; Microbial Sensitivity Tests; Morpholines; Urea | 2000 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
[Bilateral proximal cellulitis and onychomycosis in both big toes due to Fusarium solani].
Topics: Antifungal Agents; Cellulitis; Ciclopirox; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Resistance, Multiple, Fungal; Foot Dermatoses; Fusarium; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Middle Aged; Mozambique; Onychomycosis; Pyridones; Pyrimidines; Recurrence; Toes; Travel; Triazoles; Urea; Voriconazole | 2006 |
[Cutaneous infection caused by Alternaria alternata in an immunocompetent host].
Topics: Administration, Oral; Administration, Topical; Aged; Alternaria; Antifungal Agents; Biopsy; Dermatomycoses; Humans; Imidazoles; Immunocompetence; Itraconazole; Male; Skin | 2009 |
Interdigital ulcer: an unusual presentation of Candida infection.
Topics: Adult; Antifungal Agents; Biopsy; Candida albicans; Candida tropicalis; Candidiasis, Cutaneous; China; Female; Foot; Fungi; Hand; Histocytochemistry; Humans; Imidazoles; Itraconazole; Male; Microscopy; Middle Aged; Skin Ulcer; Treatment Outcome | 2011 |
Hypothyroidism-related onycholysis with Aureobasidium pullulans colonization successfully treated with antifungal therapy.
Topics: Adult; Antifungal Agents; Ascomycota; Female; Hand Dermatoses; Humans; Hypothyroidism; Imidazoles; Itraconazole; Onycholysis; Onychomycosis; Treatment Outcome | 2012 |
Majocchi granuloma in a pregnant woman.
Topics: Antifungal Agents; Dermatomycoses; Female; Humans; Imidazoles; Itraconazole; Pregnancy; Pregnancy Complications, Infectious; Trichophyton; Young Adult | 2014 |
Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Synergism; Humans; Imidazoles; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Morpholines; Species Specificity; Tacrolimus; Terbinafine; Triamcinolone Acetonide | 2018 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |